B. Weaver

High frequency of human papillomavirus detection in the vagina before first vaginal intercourse among females enrolled in a longitudinal cohort study.

J. Fortenberry, M. Shew, W. Tu, 2013, The Journal of infectious diseases.

Natural history of multiple human papillomavirus infections in female adolescents with prolonged follow-up.

J. Fortenberry, M. Shew, W. Tu, 2011, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

2. Acquisition of First Human Papillomavirus Infection Related to First Vaginal Intercourse and Other Sexually Transmitted Infections in Adolescent Women

J. Fortenberry, M. Shew, W. Tu, 2011 .

Necrotizing retinitis due to syphilis in a patient with AIDS

B. Weaver, T. Shinha, 2016, IDCases.

Association of Chlamydia trachomatis infection with redetection of human papillomavirus after apparent clearance.

J. Fortenberry, M. Shew, W. Tu, 2013, The Journal of infectious diseases.

Intranasal Antiviral Drug Delivery and Coronavirus Disease 2019 (COVID-19): A State of the Art Review

Arthur W. Wu, Elisa A. Illing, J. Ting, 2020, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Human papillomavirus in older women: new infection or reactivation?

Darron R. Brown, B. Weaver, 2013, The Journal of infectious diseases.

Low‐level persistence of human papillomavirus 16 DNA in a cohort of closely followed adolescent women

J. Fortenberry, M. Shew, W. Tu, 2011, Journal of medical virology.

DNA detection and seroprevalence of human papillomavirus in a cohort of adolescent women

J. Fortenberry, M. Shew, W. Tu, 2013, Sexually Transmitted Infections.

The Natural History of Incident Gonococcal Infection in Adolescent Women

J. Fortenberry, N. Stupiansky, B. Van Der Pol, 2011, Sexually transmitted diseases.

Intranasal Antiviral Agents and COVID-19 1 Intranasal Antiviral Drug Delivery and Coronavirus Disease (COVID-19): A State-of-the-Art

Arthur W. Wu, Elisa A. Illing, K. Sokoloski, 2020 .

Topical Oral and Intranasal Antiviral Agents for Coronavirus Disease 2019 (COVID-19).

Kyohei Itamura, Arthur W. Wu, Elisa A. Illing, 2021, Advances in experimental medicine and biology.